Skip to content
healthcare.dev

TEPADINA

NDC 70121-1630, THIOTEPA, injection, powder, for solution, from Amneal Pharmaceuticals LLC.

Product NDC
70121-1630
Status
Listed
Labeler
Amneal Pharmaceuticals LLC
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208264
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70121-1630 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • THIOTEPA15 mg/1

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
70121-1630-1701211630011 VIAL, GLASS in 1 BOX (70121-1630-1) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/559e353c-2dc0-16ba-e054-00144ff8d46c
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70121-1630

Use it

Look up 70121-1630 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70121-1630 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70121-1630. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.